BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19139287)

  • 1. Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.
    Salvatore CM; Techasaensiri C; Tagliabue C; Katz K; Leos N; Gomez AM; McCracken GH; Hardy RD
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1546-51. PubMed ID: 19139287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
    Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.
    Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Mejias A; Somers C; Chavez-Bueno S; McCracken GH; Hardy RD
    Infect Immun; 2007 Jan; 75(1):236-42. PubMed ID: 17074851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.
    Fonseca-Aten M; Salvatore CM; Mejías A; Ríos AM; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4128-36. PubMed ID: 16189089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia.
    Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Hardy RD
    Infect Immun; 2008 Feb; 76(2):732-8. PubMed ID: 18039833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia.
    Hardy RD; Rios AM; Chavez-Bueno S; Jafri HS; Hatfield J; Rogers BB; McCracken GH; Ramilo O
    Antimicrob Agents Chemother; 2003 May; 47(5):1614-20. PubMed ID: 12709330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile.
    Hardy RD; Jafri HS; Olsen K; Wordemann M; Hatfield J; Rogers BB; Patel P; Duffy L; Cassell G; McCracken GH; Ramilo O
    Infect Immun; 2001 Jun; 69(6):3869-76. PubMed ID: 11349053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.
    Tagliabue C; Salvatore CM; Techasaensiri C; Mejias A; Torres JP; Katz K; Gomez AM; Esposito S; Principi N; Hardy RD
    J Infect Dis; 2008 Oct; 198(8):1180-8. PubMed ID: 18717637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.
    Tagliabue C; Techasaensiri C; Torres JP; Katz K; Meek C; Kannan TR; Coalson JJ; Esposito S; Principi N; Leff R; Baseman JB; Hardy RD
    J Antimicrob Chemother; 2011 Oct; 66(10):2323-9. PubMed ID: 21791441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice.
    Fonseca-Aten M; Ríos AM; Mejías A; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
    Am J Respir Cell Mol Biol; 2005 Mar; 32(3):201-10. PubMed ID: 15626776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.
    Techasaensiri C; Tagliabue C; Cagle M; Iranpour P; Katz K; Kannan TR; Coalson JJ; Baseman JB; Hardy RD
    Am J Respir Crit Care Med; 2010 Sep; 182(6):797-804. PubMed ID: 20508214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background.
    Chu HW; Breed R; Rino JG; Harbeck RJ; Sills MR; Martin RJ
    Microbes Infect; 2006 Jun; 8(7):1764-72. PubMed ID: 16713727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex determination of murine seminal fluid cytokine profiles.
    Gopichandran N; Ekbote UV; Walker JJ; Brooke D; Orsi NM
    Reproduction; 2006 Mar; 131(3):613-21. PubMed ID: 16514204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.
    Ríos AM; Fonseca-Aten M; Mejías A; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Ramilo O; Hardy RD
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3970-3. PubMed ID: 16127085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice].
    Zhu C; Yu M; Gao S; Zeng Y; You X; Wu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):585-8. PubMed ID: 23746241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1α and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice.
    Tamiya S; Yoshikawa E; Ogura M; Kuroda E; Suzuki K; Yoshioka Y
    Microbiol Spectr; 2021 Dec; 9(3):e0158821. PubMed ID: 34937175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease.
    Hardy RD; Jafri HS; Olsen K; Hatfield J; Iglehart J; Rogers BB; Patel P; Cassell G; McCracken GH; Ramilo O
    Infect Immun; 2002 Feb; 70(2):649-54. PubMed ID: 11796594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pinocembrin Relieves Mycoplasma pneumoniae Infection‑Induced Pneumonia in Mice Through the Inhibition of Oxidative Stress and Inflammatory Response.
    Qian J; Xue M
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6335-6348. PubMed ID: 35917101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.
    Fonseca-Aten M; Okada PJ; Bowlware KL; Chavez-Bueno S; Mejias A; Rios AM; Katz K; Olsen K; Ng S; Jafri HS; McCracken GH; Ramilo O; Hardy RD
    Ann Allergy Asthma Immunol; 2006 Oct; 97(4):457-63. PubMed ID: 17069099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differences influence murine pulmonary responses to Stachybotrys chartarum.
    Rosenblum Lichtenstein JH; Molina RM; Donaghey TC; Brain JD
    Am J Respir Cell Mol Biol; 2006 Oct; 35(4):415-23. PubMed ID: 16690987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.